Qingquan Xiao

机构：Guizhou University of Finance and Economics, Guizhou University, Guiyang University, Guizhou Institute of Technology · ORCID：0000-0003-3921-9395

发表论文 31 篇 · 总被引 1641 次 · h-index 16

代表论文

• High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects (2022 · Nature Biotechnology · 被引 233)
• Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor (2022 · Science Translational Medicine · 被引 101)
• Development of miniature base editors using engineered IscB nickase (2023 · Nature Methods · 被引 92)
• RNA base editing therapy cures hearing loss induced by OTOF gene mutation (2023 · Molecular Therapy · 被引 50)
• Mini-dCas13X–mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy (2022 · Journal of Clinical Investigation · 被引 41)
• Engineered IscB–ωRNA system with expanded target range for base editing (2024 · Nature Chemical Biology · 被引 35)